-
Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab)
07 Oct 2025 08:49 GMT
… of moderate to severe persistent asthma (6 years and older … treating moderate to severe persistent asthma in individuals aged 6 … and older whose asthma symptoms are not well … and Saval (Latin America) and Lotus Pharmaceuticals Co., Ltd. (Thailand, Vietnam, …
-
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
06 Oct 2025 08:40 GMT
… the control of severe persistent asthma caused by an allergy. It … indicated for severe persistent allergic asthma, chronic spontaneous urticaria and chronic … and Saval (Latin America) and Lotus Pharmaceuticals Co., Ltd. (Thailand, Vietnam, Philippines …
-
Alvotech Reports Results For The First Six Months Of 2025 And Provides A Business Update
13 Aug 2025 22:04 GMT
… indicated for severe persistent allergic asthma and chronic rhinosinusitis with nasal … and Saval (Latin America) and Lotus Pharmaceuticals Co., Ltd. (Thailand, Vietnam, Philippines …
-
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
13 Aug 2025 20:15 GMT
… indicated for severe persistent allergic asthma and chronic rhinosinusitis with nasal … and Saval (Latin America) and Lotus Pharmaceuticals Co., Ltd. (Thailand, Vietnam, Philippines …
-
Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)
25 Jun 2025 08:00 GMT
… indicated for severe persistent allergic asthma, chronic rhinosinusitis with nasal polyps … and Saval (Latin America) and Lotus Pharmaceuticals Co., Ltd. (Thailand, Vietnam, Philippines …
-
China In-Focus: Regulators Clear Lotus Pharmaceuticals Asthma Drug For Clinical Trials
30 Apr 2010 17:14 GMT
… drugs, said that its asthma drug Laevo-Bambuterol has … than Bambuterol, a popular asthma drug currently on the … 2013-2014.
China-based Lotus Pharmaceuticals operates its business through … of cerebro-cardiovascular disease, asthma, and diabetes. Liang Fang …
-
Han Named Head Of OTC Unit At Lotus Pharmaceuticals
11 Dec 2009 16:17 GMT
… 11, 2009 (FinancialWire) — Lotus Pharmaceuticals, Inc. (OTCBB: LTUS) a developer … ;
<p>China-based Lotus Pharmaceuticals operates Liang Fang Pharmaceutical and … treatment of cerebro-cardiovascular disease, asthma, and diabetes.</p …
-
Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update
07 May 2025 20:45 GMT
… indicated for severe persistent allergic asthma and chronic rhinosinusitis with nasal … and Saval (Latin America) and Lotus Pharmaceuticals Co., Ltd. (Thailand, Vietnam, Philippines …
About
© 1995-2025